Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp234 | Thyroid Cancer | ECE2017

Lobectomy as a treatment option for well differentiated thyroid cancer (WDTC) between 1–4 cm: which results should we expect?

Fareleira Ana , Ferreira Patricia Andrea , Lima L Matos , Maia J Costa

Introduction: The ATA guidelines 2015 suggests lobectomy as an option for low risk thyroid tumors between 1–4 cm, although there remains some controversy once some characteristics become apparent only on pathologic examination.Objective/methods: Retrospective analysis of patients who underwent thyroid surgery in 2014 and 2015, with a histologic diagnosis of WDTC 1–4 cm in size and revision of the proportion of patients eligible for lobectomy wi...

ea0099p489 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Diabetes remission after bariatric surgery: a 10-years follow-up study

Meira Ines , Menino Joao , Goncalves Juliana , Ferreira Helena , Rita Leite Ana , Ferreira Patricia , Ribeiro Sara , Moreno Telma , Silva Diana , Freitas Paula , Lima da Costa Eduardo , Queiros Joana

Introduction: Although lifestyle measures and medical therapy are the cornerstone of type 2 diabetes (T2DM) management, achieving optimal glycemic control in T2DM patients with obesity remains challenging. There is strong and consistent evidence that bariatric surgery (BS) is an effective strategy to improve glycemia in diabetic patients and often leads to remission of T2DM in patients with obesity. The majority of the published literature supporting T2DM remission after BS ha...